Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

SCANWORKS LABS AG

History from 8 Mar 2023

UID
CHE-386.745.199
Legal form
AG
Canton
ZG
Founded
8 Mar 2023
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 149k
37k75k112k149k19 May 2026 · CHF 143k15 Jun 2026 · CHF 149k
  • shares
  • Vorzugsaktien

Record

  1. Company formed

    Founded 8 Mar 2023

    SHAB HR01-1005698675 ↗
  2. Capital increase

    Likely financing

    Paid in cash and by other means

    Nominal capital
    100’000 → 142’564
    Shares
    100’000 → 142’564
    New shares, % of post-step shares
    29.9% (42’564 new)
    Share classes
    100’000 × CHF 1 · 42’564 × CHF 1 Vorzugsaktien

    Aktienkapital neu: CHF 142'564.00 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 142'564.00 [bisher: CHF 50'000.00]. Aktien neu: 100'000 vinkulierte Namenaktien zu CHF 1.00 und 42'564 vinkulierte Namenaktien zu CHF 1.00 (Vorzugsaktien) [bisher: 100'000 vinkulierte Namenaktien zu CHF 1.00]. Kapitalband gemäss näherer Umschreibung in den Statuten. Ordentliche Kapitalerhöhung.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5
    • A new class of preferred shares was created.+1.5

    Classifier score 0.90 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006653919 ↗
  3. Capital band adopted

    SHAB HR02-1006653919 ↗
  4. Capital increase

    Likely financing

    Paid in cash and by other means

    Nominal capital
    142’564 → 149’414
    Shares
    142’564 → 149’414
    New shares, % of post-step shares
    4.6% (6’850 new)
    Share classes
    100’000 × CHF 1 · 49’414 × CHF 1 Vorzugsaktien

    Aktienkapital neu: CHF 149'414.00 [bisher: CHF 142'564.00]. Liberierung Aktienkapital neu: CHF 149'414.00 [bisher: CHF 142'564.00]. Aktien neu: 100'000 Namenaktien zu CHF 1.00 und 49'414 Namenaktien zu CHF 1.00 (Vorzugsaktien) [bisher: 42'564 vinkulierte Namenaktien zu CHF 1.00 (Vorzugsaktien) und 100'000 vinkulierte Namenaktien zu CHF 1.00]. Ordentliche Kapitalerhöhung innerhalb des Kapitalbandes.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.75 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006676719 ↗

Published by 21 Jun 2026

Latest available record · 8 Oct 2026